The need for lymph node dissection in nonmetastatic breast cancer

Annual Review of Medicine

Volumn 64, Issue , 2013, Pages 119-129

  Pesce, Catherine ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

axillary dissection; micrometastasis; positive sentinel node; sentinel lymph node; sentinel lymph node biopsy (SLNB)

Indexed keywords

ARTICLE; AXILLARY HEMATOMA; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DISEASE SEVERITY; HEMATOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MASTECTOMY; MICROMETASTASIS; MORBIDITY; NONMETASTATIC BREAST CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SEROMA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; WOUND INFECTION;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHEDEMA; SENTINEL LYMPH NODE BIOPSY;

EID: 84873032302     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-052511-135500     Document Type: Article

References (37)

1. Carter CL, Allen C, Henson DE. 1989. Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63:181-87
2. Sorlie T, Perou CM, Tibshirani R, et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98:10869-74
3. Wiechmann L, Sampson M, Stempel M, et al. 2009. Presenting features of breast cancer differ bymolecular subtype. Ann. Surg. Oncol. 16:2705-10
4. Alvarez S, Anorbe E, Alcorta P, et al. 2006. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am. J. Roentgenol. 186:1342-48
5. Houssami N, Ciatto S, Turner RM, et al. 2011. Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann. Surg. 254:243-51
6. Fisher B, Jeong JH, Anderson S, et al. 2002. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N. Engl. J. Med. 347:567-75
7. Erickson VS, Pearson ML, Ganz PA, et al. 2001. Arm edema in breast cancer patients. J. Natl. Cancer Inst. 93:96-111
8. McLaughlin SA, Wright MJ, Morris KT, et al. 2008. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J. Clin. Oncol. 26:5213-19
9. Giuliano AE, Jones RC, Brennan M, et al. 1997. Sentinel lymphadenectomy in breast cancer. J. Clin. Oncol. 15:2345-50
10. Krag DN, Anderson SJ, Julian TB, et al. 2007. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 8:881-88
11. Mansel RE, Fallowfield L, Kissin M, et al. 2006. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J. Natl. Cancer Inst. 98:599-609
12. Veronesi U, Viale G, Paganelli G, et al. 2010. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann. Surg. 251:595-600
13. Giuliano AE, Hawes D, Ballman KV, et al. 2011. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306:385-93
14. Krag DN, Anderson SJ, Julian TB, et al. 2010. Sentinel-lymph-node resection comparedwith conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 11:927-33
15. Posther KE, McCall LM, Blumencranz PW, et al. 2005. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann. Surg. 242:593-99; discussion 599-602
16. Kim T, Giuliano AE, Lyman GH. 2006. Lymphatic mapping and sentinel lymph node biopsy in earlystage breast carcinoma: a metaanalysis. Cancer 106:4-16
17. Naik AM, Fey J, Gemignani M, et al. 2004. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann. Surg. 240:462-688; discussion 468-71
18. Lucci A, McCall LM, Beitsch PD, et al. 2007. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin. Oncol. 25:3657-63
19. Gentilini O, Cremonesi M, Trifiro G, et al. 2004. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann. Oncol. 15:1348-51
20. Edge SB, Byrd DR, Compton CC, et al., eds. 2010. AJCC Staging Manual, Breast, pp. 223-36. New York: Springer. 7th ed.
21. de Boer M, van Deurzen CH, van Dijck JA, et al. 2009. Micrometastases or isolated tumor cells and the outcome of breast cancer. N. Engl. J. Med. 361:653-63
22. Tan LK, Giri D, Hummer AJ, et al. 2008. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J. Clin. Oncol. 26:1803-9
23. Tvedskov TF, Jensen MB, Balslev E, et al. 2011. Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: a nationwide study. Eur. J. Cancer 47:872-78
24. Weaver DL, Ashikaga T, Krag DN, et al. 2011. Effect of occult metastases on survival in node-negative breast cancer. N. Engl. J. Med. 364:412-21
25. Galimberti V, Cole BF, Zurrida S, et al. 2011. Update of International Breast Cancer Study Group Trial 23-01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastases in the sentinel node. San Antonio Breast Cancer Symp. Abstr. No. S3-1
26. 2000. Adjuvant therapy for breast cancer. NIH Consens. Statement 17(4):1-35
27. Hayward J, Caleffi M. 1987. The significance of local control in the primary treatment of breast cancer. LucyWortham James clinical research award. Arch. Surg. 122(11):1244-47
28. Clarke M, Collins R, Darby S, et al. 2005. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087-106
29. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. 2003. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann. Surg. Oncol. 10:1140-51
30. Bilimoria KY, Bentrem DJ, Hansen NM, et al. 2009. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J. Clin. Oncol. 27:2946-53
31. Weber WP, Barry M, Stempel MM, et al. 2012. A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: Are these procedures becoming obsolete? Ann. Surg. Oncol. 19:225-32
32. Giuliano AE, Hunt KK, Ballman KV, et al. 2011. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569-75
33. Morrow M, Harris JR, Schnitt S. 2012. Surgical margins in lumpectomy for breast cancer: bigger is not better. N. Eng. J. Med. 367:79-82
34. Reznik J, Cicchetti MG, Degaspe B, et al. 2005. Analysis of axillary coverage during tangential radiation therapy to the breast. Int. J. Radiat. Oncol. Biol. Phys. 61:163-68
35. Giuliano AE, McCall L, Beitsch P, et al. 2010. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann. Surg. 252:426-32; discussion 32-33
36. Grills IS, Kestin LL, GoldsteinN, et al. 2003. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 56:658-70
37. Yates L, Kirby A, Crichton S, et al. 2012. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes. Int. J. Radiat. Oncol. Biol. Phys. 82:2093-103